Company intelligence / Profile preview

Jiangsu Simcere Vike Biopharmaceutical

Nanjing, Jiangsu, China

Ownership: Private
Development stage: Other

Overview

Simcere Vike Biopharmaceutical is a specialized vaccine subsidiary of Simcere Pharmaceutical Group, focused on the research, development, and manufacturing of human vaccines. The company operates a large-scale production facility in Nanjing, China, which is compliant with international GMP standards. Its primary commercial products include a split-virion influenza vaccine and a human rabies vaccine (Vero cell). Simcere Vike plays a critical role in Simcere's broader strategy to expand its presence in the infectious disease and preventative medicine markets.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Biotech

Beyond the preview

Go deeper on Jiangsu Simcere Vike Biopharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Simcere Vike Biopharmaceutical.

Explore the full profile